Filing Details

Accession Number:
0001209191-13-057711
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-18 16:22:53
Reporting Period:
2013-12-16
Filing Date:
2013-12-18
Accepted Time:
2013-12-18 16:22:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265783 M Hazel Aker C/O Cadence Pharmaceuticals, Inc.
12481 High Bluff Drive, Suite 200
San Diego CA 92130
Svp, Gc & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-16 13,014 $3.51 16,759 No 4 M Direct
Common Stock Disposition 2013-12-16 13,014 $8.76 3,745 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2013-12-16 13,014 $0.00 13,014 $3.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
109,451 2022-03-14 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2013.
  2. 25% of the 155,000 shares of common stock originally subject to the option vested on 03/14/2013, and 1/48th of the remaining number of shares of common stock subject to the option vested on the first day of each full month thereafter.
  3. Not applicable to this transaction.